Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meijing Wu

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Oncoimmunology|February 7, 2019
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg <i>et al</i>. (2017)Lijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2020
International real-world study of DLL3 expression in patients with small cell lung cancerFederico Rojo, Marcelo Corassa, Dimitrios Mavroudis, et al.
Research (Washington, D.C.)|January 30, 2025
Discovery of Novel Na<sub>v</sub>1.7-Selective Inhibitors with the 1<i>H</i>-Indole-3-Propionamide Scaffold for Effective Pain ReliefGaoang Wang, Hang Wu, Yingying Wang, et al.
Neurology|April 14, 2017
Mutant IDH1 and seizures in patients with gliomaHao Chen, Jonathon Judkins, Cheddhi Thomas, et al.
Therapeutic Advances in Medical Oncology|December 17, 2021
Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline <i>BRCA1</i>/<i>2</i> mutations and hormone receptor status from the phase-3 BROCADE3 trialJean-Pierre Ayoub, Hans Wildiers, Michael Friedlander, et al.
Journal of Neurosurgery|August 6, 2016
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformationsRomuald Girard, Maged D Fam, Hussein A Zeineddine, et al.
Neurology|September 10, 2017
CSF inflammatory response after intraventricular hemorrhageMaged D Fam, Hussein A Zeineddine, Javed Khader Eliyas, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progressionDou Yu, Omar F Khan, Mario L Suvà, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient SurvivalLijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Oncoimmunology|February 7, 2019
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg <i>et al</i>. (2017)Lijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2020
International real-world study of DLL3 expression in patients with small cell lung cancerFederico Rojo, Marcelo Corassa, Dimitrios Mavroudis, et al.
Research (Washington, D.C.)|January 30, 2025
Discovery of Novel Na<sub>v</sub>1.7-Selective Inhibitors with the 1<i>H</i>-Indole-3-Propionamide Scaffold for Effective Pain ReliefGaoang Wang, Hang Wu, Yingying Wang, et al.
Neurology|April 14, 2017
Mutant IDH1 and seizures in patients with gliomaHao Chen, Jonathon Judkins, Cheddhi Thomas, et al.
Therapeutic Advances in Medical Oncology|December 17, 2021
Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline <i>BRCA1</i>/<i>2</i> mutations and hormone receptor status from the phase-3 BROCADE3 trialJean-Pierre Ayoub, Hans Wildiers, Michael Friedlander, et al.
Journal of Neurosurgery|August 6, 2016
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformationsRomuald Girard, Maged D Fam, Hussein A Zeineddine, et al.
Neurology|September 10, 2017
CSF inflammatory response after intraventricular hemorrhageMaged D Fam, Hussein A Zeineddine, Javed Khader Eliyas, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progressionDou Yu, Omar F Khan, Mario L Suvà, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient SurvivalLijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Pageof 7